Aug 12, 2026 08:01AM
Aug 12, 2026 08:01AM
Aug 10, 2026 08:02AM
Aug 10, 2026 08:01AM
Aug 3, 2026 08:00AM
Aug 3, 2026 08:00AM
Jul 14, 2026 08:00AM Acurx Pharmaceuticals Announces Scientific Poster Presentation of Ibezapolstat's Microbiome Preservation Data in Multiply-recurrent C. difficile Infection
Jul 8, 2026 08:00AM
Jun 16, 2026 08:02AM
Jun 16, 2026 08:00AM
May 19, 2026 12:25PM
May 12, 2026 07:01AM
May 4, 2026 08:00AM
Apr 29, 2026 08:00AM Acurx Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase
Apr 27, 2026 08:00AM
Apr 20, 2026 08:00AM
Apr 16, 2026 04:01PM
Apr 16, 2026 04:01PM
Apr 16, 2026 08:00AM
Apr 16, 2026 08:00AM
Apr 16, 2026 08:00AM Acurx Pharmaceuticals, Inc. Announces up to $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Apr 7, 2026 09:00AM
Mar 30, 2026 07:01AM
Mar 13, 2026 07:01AM
Mar 9, 2026 08:01AM
Feb 16, 2026 08:01AM
Feb 2, 2026 08:00AM
Nov 18, 2025 08:00AM Health~Holland Awards Another Innovative Research Grant for DNA Pol IIIC Inhibitors to Leiden University Medical Center and Acurx Pharmaceuticals
Nov 12, 2025 07:01AM
Nov 10, 2025 08:00AM
Oct 28, 2025 08:03AM
Oct 28, 2025 08:00AM
Oct 27, 2025 08:00AM
Oct 9, 2025 07:31AM
Oct 9, 2025 07:30AM Australian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors
Oct 1, 2025 06:57AM
Sep 30, 2025 07:31AM
Sep 30, 2025 07:30AM
Sep 3, 2025 07:01AM
Sep 3, 2025 07:01AM
Aug 12, 2025 07:01AM
Jul 31, 2025 09:25AM Acurx announces 1-for-20 reverse stock split effective August 4
Jul 31, 2025 09:25AM
Jul 24, 2025 07:01AM
Jun 17, 2025 09:47PM
Jun 17, 2025 09:47PM
Jun 17, 2025 07:01AM
Jun 9, 2025 07:30AM
May 13, 2025 07:01AM Acurx Pharmaceuticals, Inc. Reports First Quarter Results and Provides Business Update
Apr 30, 2025 07:30AM

328,440 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All